Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Brenner

Showing results (21-30 of 226) with videos related to

Pageof 23
Sort By:
Cancer Gene Therapy|October 13, 2012
Will T-cell therapy for cancer ever be a standard of care?M K Brenner
Seminars in Hematology|December 14, 1999
Cure of leukemiaM K Brenner, D Pinkel
Cellular Immunology|January 1, 1981
T-cell help in human in vitro antibody-producing systems: role of inhibitory T cells in masking allogeneic helpM K Brenner, A J Munro
Leukemia|January 1, 1992
Immunotherapy of leukemiaM K Brenner, H E Heslop
British Journal of Hospital Medicine|March 1, 1989
Current role and status of bone marrow transplantationM K Brenner, H G Prentice
Journal of Hematotherapy|January 1, 1994
Gene marking to improve the outcome of autologous bone marrow transplantationM K Brenner, D R Rill
Cytotherapy|July 10, 2003
Is retroviral gene marking too dangerous to use?M K Brenner, H E Heslop
Bailliere'S Clinical Haematology|July 1, 1991
Graft versus leukaemia effects after marrow transplantation in manM K Brenner, H E Heslop
Acta Haematologica|January 1, 1987
Bone marrow transplantation in acute or chronic leukaemiaH G Prentice, M K Brenner
Clinical and Experimental Immunology|June 1, 1983
Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune diseaseM K Brenner, M E North
Pageof 23

Showing results (21-30 of 226) with videos related to

Sort By:
Pageof 23
Cancer Gene Therapy|October 13, 2012
Will T-cell therapy for cancer ever be a standard of care?M K Brenner
Seminars in Hematology|December 14, 1999
Cure of leukemiaM K Brenner, D Pinkel
Cellular Immunology|January 1, 1981
T-cell help in human in vitro antibody-producing systems: role of inhibitory T cells in masking allogeneic helpM K Brenner, A J Munro
Leukemia|January 1, 1992
Immunotherapy of leukemiaM K Brenner, H E Heslop
British Journal of Hospital Medicine|March 1, 1989
Current role and status of bone marrow transplantationM K Brenner, H G Prentice
Journal of Hematotherapy|January 1, 1994
Gene marking to improve the outcome of autologous bone marrow transplantationM K Brenner, D R Rill
Cytotherapy|July 10, 2003
Is retroviral gene marking too dangerous to use?M K Brenner, H E Heslop
Bailliere'S Clinical Haematology|July 1, 1991
Graft versus leukaemia effects after marrow transplantation in manM K Brenner, H E Heslop
Acta Haematologica|January 1, 1987
Bone marrow transplantation in acute or chronic leukaemiaH G Prentice, M K Brenner
Clinical and Experimental Immunology|June 1, 1983
Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune diseaseM K Brenner, M E North
Pageof 23